
Dr Ferruccio De Lorenzo
Consultant Physician in General Medicine
MD, Ph.D (Imperial College), FRCP, FBIHS
Languages spoken: English Italian
50 to 80% of cases of Heart Diseases are caused by modifiable risk factors. Preventive treatment is very effective to stave off heart diseases principally in people aged 30 and 75 who have not yet shown any symptoms.
Dr Ferruccio De Lorenzo
Consultant Physician in General Medicine
MD, Ph.D (Imperial College), FRCP, FBIHS
Languages spoken: English Italian
50 to 80% of cases of Heart Diseases are caused by modifiable risk factors. Preventive treatment is very effective to stave off heart diseases principally in people aged 30 and 75 who have not yet shown any symptoms.
Appointments available at:
Cromwell HospitalPatient Age Group
AdultsYear qualified
1990Specialties
General (internal) medicineGender
MaleClinical Interests
About Dr Ferruccio De Lorenzo
EXPERT COLUMNIST
Ibero-American Society of Scientific Information on Medical and Healthcare (SIIC)
MEMBER OF THE ADVISORY & EDITORIAL BOARD
Advances in Therapy- international peer-reviewed journal dedicated to the rapid publication of studies in clinical medicine, including research on existing drugs and drugs in development across a range of therapeutic areas. (Springer Healthcare Communications)
Cardiovascular Disorders and Medicine (http://oatext.com/Cardiovascular-Disorders-and-Medicine-CDM.php)
Trends in Medicine and Therapeutics (TMT)
REFEREE TO:
MRC- Medical Research Council (reviewer international grant applications)
QJM- Monthly Journal of the Association of Physicians
Journal of Thrombosis and Haemostasis
Annals of Internal Medicine
Archives of Internal Medicine
International Journal of Cardiology
Arteriosclerosis, Thrombosis & Vascular Biology ATVB
Current HIV Research
Southern Medical Journal
Archives of Medical Research
Journal of Acquired Immune Deficiency Syndromes (JAIDS)
HIV/AIDS - Research and Palliative Care
Advances in Therapy
Vascular health and risk management
Key published papers:
Evidence-based cardiovascular disease prevention. Cardiovascular Disorders and Medicine 2017; 2 (2): 1-2
De Lorenzo F, Feher M, Martin J, Collot-Teixeira S, Dotsenko O, McGregor J. Statin Therapy: Evidence beyond lipid lowering contributing to plaque stability. Curr Med Chem 2006; 13: 3385-93
De Lorenzo F. UK screening plans. The Lancet 2008; 372: 447-8
De Lorenzo F. Evidence-based screening to prevent and control cardiovascular disease worldwide. Editorial, Int J Clin Pract. 2014 May;68(5):534-5
De Lorenzo F. Cardiovascular disease primary prevention failure: A sixth of patients with a QRISK2 score below 10% were started on statins, despite the guidelines-Expert Opinion. Trends In Medicine 2017 (November 10); 17: DOI: 10.15761/TiM.1000101
NHS Base (trust)
Professional memberships
